Bruker (BRKR) Competitors $56.88 -2.13 (-3.61%) As of 04:00 PM Eastern Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends BRKR vs. MTD, WAT, ILMN, TECH, BIO, CRL, PACB, HBIO, TMO, and AShould you be buying Bruker stock or one of its competitors? The main competitors of Bruker include Mettler-Toledo International (MTD), Waters (WAT), Illumina (ILMN), Bio-Techne (TECH), Bio-Rad Laboratories (BIO), Charles River Laboratories International (CRL), Pacific Biosciences of California (PACB), Harvard Bioscience (HBIO), Thermo Fisher Scientific (TMO), and Agilent Technologies (A). These companies are all part of the "life sciences tools & services" industry. Bruker vs. Mettler-Toledo International Waters Illumina Bio-Techne Bio-Rad Laboratories Charles River Laboratories International Pacific Biosciences of California Harvard Bioscience Thermo Fisher Scientific Agilent Technologies Bruker (NASDAQ:BRKR) and Mettler-Toledo International (NYSE:MTD) are both computer and technology companies, but which is the superior stock? We will compare the two businesses based on the strength of their community ranking, media sentiment, earnings, analyst recommendations, institutional ownership, dividends, risk, valuation and profitability. Do institutionals & insiders hold more shares of BRKR or MTD? 79.5% of Bruker shares are held by institutional investors. Comparatively, 95.1% of Mettler-Toledo International shares are held by institutional investors. 28.3% of Bruker shares are held by insiders. Comparatively, 1.9% of Mettler-Toledo International shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth. Does the MarketBeat Community prefer BRKR or MTD? Bruker received 307 more outperform votes than Mettler-Toledo International when rated by MarketBeat users. Likewise, 64.78% of users gave Bruker an outperform vote while only 56.75% of users gave Mettler-Toledo International an outperform vote. CompanyUnderperformOutperformBrukerOutperform Votes67764.78% Underperform Votes36835.22% Mettler-Toledo InternationalOutperform Votes37056.75% Underperform Votes28243.25% Which has more risk & volatility, BRKR or MTD? Bruker has a beta of 1.17, indicating that its stock price is 17% more volatile than the S&P 500. Comparatively, Mettler-Toledo International has a beta of 1.12, indicating that its stock price is 12% more volatile than the S&P 500. Is BRKR or MTD more profitable? Mettler-Toledo International has a net margin of 21.15% compared to Bruker's net margin of 9.41%. Bruker's return on equity of 21.52% beat Mettler-Toledo International's return on equity.Company Net Margins Return on Equity Return on Assets Bruker9.41% 21.52% 6.69% Mettler-Toledo International 21.15%-531.78%24.79% Does the media prefer BRKR or MTD? In the previous week, Bruker had 12 more articles in the media than Mettler-Toledo International. MarketBeat recorded 18 mentions for Bruker and 6 mentions for Mettler-Toledo International. Mettler-Toledo International's average media sentiment score of 0.91 beat Bruker's score of 0.57 indicating that Mettler-Toledo International is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Bruker 5 Very Positive mention(s) 3 Positive mention(s) 6 Neutral mention(s) 0 Negative mention(s) 1 Very Negative mention(s) Positive Mettler-Toledo International 6 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Which has stronger valuation & earnings, BRKR or MTD? Mettler-Toledo International has higher revenue and earnings than Bruker. Bruker is trading at a lower price-to-earnings ratio than Mettler-Toledo International, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioBruker$2.96B2.91$427.20M$2.0827.35Mettler-Toledo International$3.79B7.22$788.78M$37.0934.94 Do analysts recommend BRKR or MTD? Bruker presently has a consensus price target of $74.45, indicating a potential upside of 30.90%. Mettler-Toledo International has a consensus price target of $1,351.25, indicating a potential upside of 4.28%. Given Bruker's stronger consensus rating and higher probable upside, equities research analysts clearly believe Bruker is more favorable than Mettler-Toledo International.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Bruker 0 Sell rating(s) 5 Hold rating(s) 7 Buy rating(s) 0 Strong Buy rating(s) 2.58Mettler-Toledo International 1 Sell rating(s) 6 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.11 SummaryBruker and Mettler-Toledo International tied by winning 9 of the 18 factors compared between the two stocks. Get Bruker News Delivered to You Automatically Sign up to receive the latest news and ratings for BRKR and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart BRKR vs. The Competition Export to ExcelMetricBrukerAnalytical instruments IndustryComputer SectorNASDAQ ExchangeMarket Cap$8.62B$5.90B$26.94B$9.13BDividend Yield0.33%0.43%2.77%4.03%P/E Ratio27.3529.94235.8417.33Price / Sales2.914.123,187.01137.35Price / Cash17.0144.7534.2435.97Price / Book5.642.398.364.80Net Income$427.20M$2.94M$669.74M$224.91M7 Day Performance-6.42%-0.18%2.06%1.77%1 Month Performance-1.61%-3.78%4.13%2.22%1 Year Performance-18.39%-21.49%27.10%20.67% Bruker Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)BRKRBruker4.9807 of 5 stars$56.88-3.6%$74.45+30.9%-16.8%$8.62B$2.96B27.359,707Analyst ForecastShort Interest ↑News CoverageMTDMettler-Toledo International4.0135 of 5 stars$1,260.15+4.1%$1,351.25+7.2%+9.6%$26.59B$3.76B33.9818,000WATWaters4.4017 of 5 stars$398.04+4.7%$384.71-3.3%+31.7%$23.63B$2.91B37.987,900ILMNIllumina4.6432 of 5 stars$144.05+5.4%$165.63+15.0%+1.7%$22.85B$4.39B-14.469,300Short Interest ↓News CoverageTECHBio-Techne4.0646 of 5 stars$75.31+2.7%$82.00+8.9%+6.5%$11.97B$1.17B80.123,100BIOBio-Rad Laboratories3.9785 of 5 stars$348.19+1.9%$394.20+13.2%+9.3%$9.75B$2.58B-12.748,030Analyst ForecastShort Interest ↑Analyst RevisionNews CoverageCRLCharles River Laboratories International4.8374 of 5 stars$190.31+2.3%$214.00+12.4%-19.8%$9.73B$4.06B23.8221,800Analyst ForecastShort Interest ↑News CoveragePACBPacific Biosciences of California1.917 of 5 stars$1.97-6.2%$2.95+50.0%-75.1%$539.51M$173.15M-1.35730HBIOHarvard Bioscience1.1446 of 5 stars$1.85-2.6%N/A-58.1%$80.69M$97.73M-5.61490Short Interest ↑News CoveragePositive NewsTMOThermo Fisher Scientific4.9807 of 5 stars$556.59+2.6%$650.52+16.9%+3.6%$212.90B$42.37B34.90122,000Analyst UpgradeNews CoveragePositive NewsAAgilent Technologies4.6919 of 5 stars$142.29+3.5%$143.62+0.9%+10.9%$40.64B$6.51B32.1918,100Short Interest ↓News Coverage Related Companies and Tools Related Companies MTD Competitors WAT Competitors ILMN Competitors TECH Competitors BIO Competitors CRL Competitors PACB Competitors HBIO Competitors TMO Competitors A Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:BRKR) was last updated on 1/17/2025 by MarketBeat.com Staff From Our PartnersI was wrong. Dead wrong. I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredStunning Trump Exec Order LeakedThis secret document contains stunning details about Donald Trump’s very first order of business… the minute h...Banyan Hill Publishing | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode in 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredMost People Are Dead Wrong.Turn on any financial news outlet at any given moment and within minutes you're guaranteed to see headlines ab...Brownstone Research | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowAll of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you k...Crypto Swap Profits | Sponsoredliberals FOOLED by Elon’s shocking surpriseElon Musk and Donald Trump fooled everyone. They said it was to “save free speech”... Or “fix what the l...StocksToTrade | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Bruker Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Bruker With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free BRKR Stock Alerts